Rebekah Oyler, MD
Dermatology · Raleigh, NCNPI 1649248386
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (54.4%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. AbbVie accounts for 70.5% of it on its own, with 32 other manufacturers making up the rest. Reporting peaked in 2019 at $40,572 and has fallen 85.0% since, to $6,103 in 2025. Among dermatology clinicians in NC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 903 payments — averaging $80.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$51K
- UCB, Inc.$5K
- Sun Pharmaceutical Industries Inc.$2K
- Johnson & Johnson$2K
- Lilly USA, LLC$1K
- Regeneron Healthcare Solutions, Inc.$1K
- plus $10K from 27 others
Across 1 payment — averaging $6660.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$7K
What the payments were for
- Consulting fees$3,3705%
- Speaking & faculty fees$39,40054%
- Travel & lodging$5,6968%
- Food & beverage$23,28232%
- Education$7301%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 232 | $51,067 |
| UCB, Inc. | 77 | $5,102 |
| Sun Pharmaceutical Industries Inc. | 59 | $1,993 |
| Johnson & Johnson | 74 | $1,687 |
| Lilly USA, LLC | 63 | $1,235 |
| Regeneron Healthcare Solutions, Inc. | 31 | $1,180 |
| Pfizer | 61 | $1,065 |
| E.r. Squibb & Sons, L.L.C. | 51 | $1,011 |
| Novartis | 38 | $1,005 |
| Sanofi | 21 | $917 |
| Amgen | 18 | $765 |
| Merz North America, Inc. | 8 | $696 |
| Arcutis Biotherapeutics, Inc. | 16 | $599 |
| Galderma Laboratories, L.p. | 25 | $561 |
| Incyte Corporation | 28 | $537 |
| LEO Pharma Inc. | 30 | $464 |
| Almirall LLC | 7 | $449 |
| Dermavant Sciences, Inc. | 17 | $421 |
| Journey Medical Corporation | 5 | $371 |
| Organon | 5 | $278 |
| VYNE Pharmaceuticals Inc. | 5 | $227 |
| Genentech USA, Inc. | 4 | $156 |
| Verrica Pharmaceuticals Inc. | 1 | $125 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 2 | $120 |
| Organogenesis Inc. | 1 | $97 |
| Aclaris Therapeutics, Inc. | 4 | $94 |
| Paratek Pharmaceuticals, Inc. | 6 | $88 |
| Strata Skin Sciences, Inc. | 8 | $57 |
| Biofrontera Inc. | 2 | $33 |
| Bristol Myers Squibb | 1 | $25 |
| EPI Health, LLC | 1 | $18 |
| Botanix SB Inc | 1 | $18 |
| DUSA Pharmaceuticals, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$72,478 in reported general payments places this provider in the 95th percentile of 475 dermatology providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira PenAdalimumab | 11 | $74,626 |
| Betamethasone Dipropionate | 55 | $2,210 |
| Doxycycline Hyclate | 66 | $1,374 |
| Triamcinolone Acetonide | 105 | $1,101 |
| Tacrolimus | 12 | $1,011 |
| Imiquimod | 47 | $1,000 |
| Metronidazole | 17 | $821 |
| Finasteride | 34 | $374 |
| CiclopiroxCiclopirox Olamine | 16 | $225 |
| Hydrocortisone | 40 | $209 |
| ValacyclovirValacyclovir Hcl | 15 | $205 |
| Cephalexin | 13 | $147 |
| Prednisone | 65 | $145 |
| Hydroxyzine Hcl | 20 | $105 |
| Mupirocin | 17 | $83 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Raleigh
- Beth Schulz-ButulisRaleigh$18K
- Steven FeldmanWinston Salem$3.4M
- Nicole SeminaraHuntersville$1.4M
- Andrew LeeElkin$702K
- Christopher SayedChapel Hill$690K
- William HooverConcord$594K
- Patrick McElgunnCharlotte$565K
- George MagelHickory$554K
- Muneeb ShahClinton$451K
- John SoderbergCary$398K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.